We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×

Recent advances in multiplex immunoassays

    Christophe A Marquette

    * Author for correspondence

    Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, Equipe Génie Enzymatique, Membranes Biomimétiques et Assemblages Supramoléculaires (GEMBAS), Université Lyon 1 - CNRS 5246 ICBMS, Bâtiment CPE 43, bd du 11 novembre 1918, 69622 Villeurbanne, Cedex, France.

    ,
    Benjamin P Corgier

    AXO Science, 34 Rue du Mail, 69004 Lyon, France

    &
    Loïc J Blum

    Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, Equipe Génie Enzymatique, Membranes Biomimétiques et Assemblages Supramoléculaires (GEMBAS), Université Lyon 1 - CNRS 5246 ICBMS, Bâtiment CPE 43, bd du 11 novembre 1918, 69622 Villeurbanne, Cedex, France

    Published Online:https://doi.org/10.4155/bio.12.56

    The present review reports on the lastest developments in multiplex immunoassays. The selected examples are classified through their detection strategy (fluorescence, chemiluminescence, colorimetry or labeless) and their assay format (standard microtiter plate, polymeric membranes and glass slides). Finally, the degree of integration in a complete system, incorporating fluid handling and detection was also taken into account.

    Papers of special note have been highlighted as: ▪ of interest

    References

    • Tomizaki KY, Usui K, Mihara H. Protein-detecting microarrays: current accomplishments and requirements. ChemBioChem6(5),782–799 (2005).
    • Stoll D, Templin MF, Bachmann J, Joos TO. Protein microarrays: applications and future challenges. Curr. Opin. Drug. Disc. Dev.8(2),239–252 (2005).
    • Ekins R, Chu F, Biggart E. Development of microspot multi-analyte ratiometric immunoassay using dual fluorescent-labeled antibodies. Anal. Chim. Acta227(1),73–96 (1989).
    • Pease AC, Solas D, Sullivan EJ, Cronin MT, Holmes CP, Fodor SPA. Light-generated oligonucleotide arrays for rapid DNA-sequence analysis. Proc. Natl Acad. Sci. USA91(11),5022–5026 (1994).
    • Ragoussis J, Elvidge G. Affymetrix GeneChip® system: moving from research to the clinic. Expert Rev. Mol. Med.6(2),145–152 (2006).
    • Selby C. Interference in immunoassay. Ann. Clin. Biochem.36,704–721 (1999).
    • Pla-Roca M, Leulmi RF, Djambazian H, Sundararajan S, Juncker D. Addressable nanowell arrays formed using reversibly sealable hybrid elastomer-metal stencils. Anal. Chem. (2012) (In press).
    • Fresiello L, Franchin T, Iadanza E, De Vivo L. Clinical relevance of donor specific antibodies (DSA) detected by luminex technology: an early systematic review and meta-analysis of the literature for a hospital-based health technology assessment project. Clin. Chem. Lab. Med.49,S755–S755 (2011).
    • Tait BD, Hudson F, Cantwell L et al. Review article: Luminex technology for HLA antibody detection in organ transplantation. Nephrology14(2),247–254 (2009).
    • 10  Mao X, Xu H, Zeng QX, Zeng LW, Liu GD. Molecular beacon-functionalized gold nanoparticles as probes in dry-reagent strip biosensor for DNA analysis. Chem. Comm.21,3065–3067 (2009).▪ The device that led to the first commercial multiplexed immunoassays.
    • 11  Ngom B, Guo YC, Wang XL, Bi DR. Development and application of lateral flow test strip technology for detection of infectious agents and chemical contaminants: a review. Anal. Bioanal. Chem.397(3),1113–1135 (2010).
    • 12  Mark D, Haeberle S, Roth G, von Stetten F, Zengerle R. Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications. Chem. Soc. Rev.39(3),1153–1182 (2010).
    • 13  He YQ, Zeng K, Gurung AS et al. Visual detection of single-nucleotide polymorphism with hairpin oligonucleotide-functionalized gold nanoparticles. Anal. Chem.82(17),7169–7177 (2010).
    • 14  Deinhofer K, Sevcik H, Balic N et al. Microarrayed allergens for IgE profiling. Methods32(3),249–254 (2004).
    • 15  Murng SHK, Egner W, Shrimpton A, Sargur R, Cowley D, Lees K. A study of ISAC (immuno solid-phase allergen chip) assay performance and interpretation. Clin. Exp. Allergy41(12),1839–1839 (2011).
    • 16  Heaps AG, El-Shanawany T, Selwood C et al. Analysis of the serum IgE repertoire in hyper IgE syndrome (HIGE) patients using an immuno solid-phase allergen chip (ISAC). Clin. Exp. Immunol.16012–16013 (2010).
    • 17  Preininger C, Domnanich P, Sauer U, Pultar J. Protein microarray for the analysis of human melanoma biomarkers. Sens. Actuators B139(1),2–8 (2009).
    • 18  Sauer U, Domnanich P, Preininger C. Protein chip for the parallel quantification of high and low abundant biomarkers for sepsis. Anal. Biochem.419(1),46–52 (2011).
    • 19  Thompson NL, Burghardt TP, Axelrod D. Measuring surface dynamics of biomolecules by total internal-reflection fluorescence with photobleaching recovery or correlation spectroscopy. Biophys. J.33(3),435–454 (1981).
    • 20  Kemmler M, Koger B, Sulz G et al. Compact point-of-care system for clinical diagnostics. Sens. Actuators B139(1),44–51 (2009).
    • 21  Pawlak M, Schick E, Bopp MA, Schneider MJ, Oroszlan P, Ehrat M. Zeptosens’ protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics2(4),383–393 (2002).
    • 22  McBride JD, Gabriel FG, Fordham J et al. Screening autoantibody profiles in systemic rheumatic disease with a diagnostic protein microarray that uses a filtration-assisted nanodot array luminometric immunoassay (NALIA). Clin. Chem.54(5),883–890 (2008).
    • 23  Magliulo M, P Simoni, M Guardigli et al. A rapid multiplexed chemiluminescent immunoassay for the detection of Escherichia coli O157:H7, Yersinia enterocolitica, Salmonella typhimurium, and Listeria monocytogenes pathogen bacteria. J. Agric. Food Chem.55(13),4933–4939 (2007).
    • 24  Pickering JW, Hoopes JD, Groll MC et al. A 22-plex chemiluminescent microarray for pneumococcal antibodies. Am. J. Clin. Pathol.128(1),23–31 (2007).
    • 25  Alvarez JC. The evaluation of the first meprobamate, zopiclone, zolpidem and zaleplon antibodies using biochip multiplexing technology from randox in plasma, serum and whole blood. Clin. Chem. Lab. Med.49,S188 (2011).
    • 26  van Pelt J, Romijn FPHTM. Long-term quality control of the cytokine & growth factors and cell adhesion molecule arrays at the randox evidence investigator. J. Med. Biochem.28(4),300–304 (2009).
    • 27  Sachdeva N, Yoon HS, Oshima K, Garcia D, Goodkin K, Asthana D. Biochip array-based analysis of plasma cytokines in HIV patients with immunological and virological discordance. Scand. J. Immunol.65(6),549–554 (2007).
    • 28  Usui K, Tomizaki K-Y, Ohyama T, Nokiharab K, Mihara H. A novel peptide microarray for protein detection and analysis utilizing a dry peptide array system. Mol. BioSyst.2113–121 (2006).
    • 29  Usui-Aoki K, Shimada K, Koga H. A novel antibody microarray format using non-covalent antibody immobilization with chemiluminescent detection. Mol. BioSyst.3(1),36–42 (2007).
    • 30  Huelseweh B, Ehricht R, Marschall H-J. A simple and rapid protein array based method for the simultaneous detection of biowarfare agents. Proteomics6(10),2972–2981 (2006).
    • 31  Santos A, Clemente S, Bartolo I et al. Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic. Diagn. Microbiol. Infect. Dis.71(1),90–92 (2011).
    • 32  Pinho TS, Nazer SC, Bertho AL, Pinheiro MFC, Teixeira EH, Fellows IB. Abbott Determine™ HIV-1/2 validation as qualitative screening test. Clin. Chem.46(6),A46 (2000).
    • 33  Le Goff GC, Brès J-C, Rigal D, Blum LJ, Marquette CA. Robust, high-throughput solution for blood group genotyping. Anal. Chem.82(14),6185–6192 (2010).
    • 34  Desmet C, Le Goff GC, Bres JC, Rigal D, Blum LJ, Marquette CA. Multiplexed immunoassay for the rapid detection of anti-tumor-associated antigens antibodies. Analyst136(14),2918–2924 (2011).
    • 35  Bhatta D, Michel AA, Marti Villalba M et al. Optical microchip array biosensor for multiplexed detection of bio-hazardous agents. Biosens. Bioelectron.30(1),78–86 (2011).
    • 36  Suarez G, Jin Y-H, Auerswald J et al. Lab-on-a-chip for multiplexed biosensing of residual antibiotics in milk. Lab. Chip.9(11),1625–1630 (2009).▪ A promising labeless detection model; a fully integrated system.
    • 37  Adrian J, Pasche S, Pinacho DG et al. Wavelength-interrogated optical biosensor for multi-analyte screening of sulfonamide, fluoroquinolone, beta-lactam and tetracycline antibiotics in milk. Trends Anal. Chem.28(6),769–777 (2009).
    • 38  Villiers M-B, Cortès S, Brakha C et al. Peptide-protein microarrays and surface plasmon resonance detection: biosensors for versatile biomolecular interaction analysis. Biosens. Bioelectron.26(4),1554–1559 (2010).
    • 39  Cherif B, Roget A, Villiers CL et al. Clinically related protein-peptide interactions monitored in real time on novel peptide chips by surface plasmon resonance imaging. Clin. Chem.52(2),255–262 (2006).
    • 40  Cherif B, Villiers CL, Paranhos-Baccala G et al. Design and application of a microarray for fluorescence and surface plasmon resonance imaging analysis of peptide-antibody interactions. J. Biomed. Nanotech.2(1),29–35 (2006).
    • 41  Dostalek J, Pribyl J, Homola J, Skladal P. Multichannel SPR biosensor for detection of endocrine-disrupting compounds. Anal. Bioanal. Chem.389(6),1841–1847 (2007).
    • 101  lmmuno Concepts. www.immunoconcepts.com/disease-diagnostics/systemic-rheumatic-disease/colorimetric-microarray